Intensive care admissions for severe immune-related adverse events associated with immune checkpoint inhibitor therapy: a 10-year cohort study
{{output}}
Objective: This study aimed to assess the prevalence of immune-related adverse events (irAEs) among patients admitted to the intensive care unit (ICU) while receiving immune checkpoint inhibitor (ICI) therapy, and to describe the... ...
